↓ Skip to main content

Helicobacter pylori

Overview of attention for book
Cover of 'Helicobacter pylori'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 What are the biochemical and physiological implications of the new genetic information?
  3. Altmetric Badge
    Chapter 2 The urease system of Helicobacter pylori
  4. Altmetric Badge
    Chapter 3 The amphibiotic relationship of Helicobacter pylori and humans
  5. Altmetric Badge
    Chapter 4 Helicobacter pylori is pathogenic flora
  6. Altmetric Badge
    Chapter 5 Disease-specific Helicobacter pylori virulence factors: the role of cagA, vacA, iceA, babA2 alone or in combination
  7. Altmetric Badge
    Chapter 6 Factors associated with disappearance of Helicobacter pylori in the West
  8. Altmetric Badge
    Chapter 7 Factors associated with disappearance of Helicobacter pylori in the Far East
  9. Altmetric Badge
    Chapter 8 Differences in prevalence of Helicobacter pylori and disease outcomes according to race/environmental factors in Southeast Asia
  10. Altmetric Badge
    Chapter 9 Infection with Helicobacter heilmannii (formerly Gastrospirillum horminis ): characterization, epidemiology and therapy
  11. Altmetric Badge
    Chapter 10 Hepatobiliary Helicobacters : recognized animal pathogens with suspected pathogenic potential in humans
  12. Altmetric Badge
    Chapter 11 Novel Helicobacter species in the intestine
  13. Altmetric Badge
    Chapter 12 Diagnosis of Helicobacter pylori infection: faecal antigen determination
  14. Altmetric Badge
    Chapter 13 Pitfalls in Helicobacter pylori diagnosis
  15. Altmetric Badge
    Chapter 14 Overview of immune and inflammatory changes due to Helicobacter infection
  16. Altmetric Badge
    Chapter 15 Interaction of Helicobacter pylori with gastric epithelium
  17. Altmetric Badge
    Chapter 16 Helicobacter pylori and the epithelial barrier: role of oxidative injury
  18. Altmetric Badge
    Chapter 17 Immuno-inflammatory response to Helicobacter pylori in children
  19. Altmetric Badge
    Chapter 18 Severity and reversibility of mucosal inflammation in children and adolescents infected with Helicobacter pylori
  20. Altmetric Badge
    Chapter 19 Elimination of Helicobacter pylori is dependent on a Th2 response
  21. Altmetric Badge
    Chapter 20 Elimination of Helicobacter pylori is not dependent on a Th2 cytokine response
  22. Altmetric Badge
    Chapter 21 The inflamatory activity in Helicobacter pylori infection is predominantly organism related
  23. Altmetric Badge
    Chapter 22 The inflammatory activity in Helicobacter pylori infection is predominantly host-related
  24. Altmetric Badge
    Chapter 23 Helicobacter pylori gastritis — a global view
  25. Altmetric Badge
    Chapter 24 Unusual forms of gastric inflammation and their relationship to Helicobacter pylori infection
  26. Altmetric Badge
    Chapter 25 Can atrophic gastritis be diagnosed in the presence of Helicobacter pylori infection?
  27. Altmetric Badge
    Chapter 26 Mechanisms involved in gastric atrophy
  28. Altmetric Badge
    Chapter 27 Intestinal metaplasia: types, mechanisms of origin, and role in gastric cancer histogenesis
  29. Altmetric Badge
    Chapter 28 Long-term proton pump inhibitor therapy accelerates the onset of atrophic gastritis in Helicobacter pylori -positive patients
  30. Altmetric Badge
    Chapter 29 Proton pump inhibitors do not accelerate the development of gastric atrophy in Helicobacter pylori gastritis
  31. Altmetric Badge
    Chapter 30 Autoimmune gastritis via mimicking does occur
  32. Altmetric Badge
    Chapter 31 Autoimmune gastritis and antigenic mimicking
  33. Altmetric Badge
    Chapter 32 Carditis and intestinal metaplasia of the cardia is reflux related
  34. Altmetric Badge
    Chapter 33 Carditis and cardia intestinal metaplasia are Helicobacter pylori -related
  35. Altmetric Badge
    Chapter 34 Is gastric metaplasia in Helicobacter pylori really gastric?
  36. Altmetric Badge
    Chapter 35 Extragastric manifestations of Helicobacter pylori — are they relevant?
  37. Altmetric Badge
    Chapter 36 Peptic ulcer disease — the transitional zones are important
  38. Altmetric Badge
    Chapter 37 What causes Helicobacter pylori -negative non-NSAID-related ulcers?
  39. Altmetric Badge
    Chapter 38 From the pump to the helix
  40. Altmetric Badge
    Chapter 39 Mechanisms involved in the development of hypochlorhydria and pangastritis in Helicobacter pylori infection
  41. Altmetric Badge
    Chapter 40 Effect of Helicobacter pylori infection on gastric acid control using proton pump inhibitors
  42. Altmetric Badge
    Chapter 41 Rebound acid hypersecretion after acid-suppressive therapy
  43. Altmetric Badge
    Chapter 42 Gastric consequences of proton pump inhibitor therapy and Helicobacter pylori eradication
  44. Altmetric Badge
    Chapter 43 Current concepts of dyspepsia: the role of the nervous system
  45. Altmetric Badge
    Chapter 44 How to explain outcome differences in dyspepsia studies
  46. Altmetric Badge
    Chapter 45 Helicobacter pylori eradication for dyspepsia is clinically useful
  47. Altmetric Badge
    Chapter 46 Dyspepsia is no indication for Helicobacter pylori eradication
  48. Altmetric Badge
    Chapter 47 Role of Helicobacter pylori infection in NSAID-associated gastropathy
  49. Altmetric Badge
    Chapter 48 Role of Helicobacter pylori in NSAID gastrophy: can H. pylori infection be beneficial?
  50. Altmetric Badge
    Chapter 49 Helicobacter pylori and non-steroidal anti-inflammatory drugs
  51. Altmetric Badge
    Chapter 50 The impact of a test-and-treat strategy for Helicobacter pylori : the United States perspective
  52. Altmetric Badge
    Chapter 51 Test-and-treat strategy in dyspepsia — the European perspective
  53. Altmetric Badge
    Chapter 52 The impact of the ‘test-and-treat’ strategies for Helicobacter pylori infection — an Asian perspective?
  54. Altmetric Badge
    Chapter 53 Rodent models for Helicobacter -induced gastric cancer
  55. Altmetric Badge
    Chapter 54 Helicobacter pylori and gastric cancer: the risk is real
  56. Altmetric Badge
    Chapter 55 Helicobacter pylori in gastric malignancy: role of oxidants, antioxidants and other co-factors
  57. Altmetric Badge
    Chapter 56 Gastric markers of pre-malignancy are not reversible
  58. Altmetric Badge
    Chapter 57 The case for the reversibility of gastric dysplasia/neoplasia
  59. Altmetric Badge
    Chapter 58 Evaluation of the long-term outcome of Helicobacter pylori -related gastric mucosa-associated lymphoid tissue (MALT) lymphoma
  60. Altmetric Badge
    Chapter 59 Current state-of-the-art management for Helicobacter pylori infection: global perspective
  61. Altmetric Badge
    Chapter 60 Guidelines for therapy of Helicobacter pylori infection — a world perspective
  62. Altmetric Badge
    Chapter 61 Bismuth triple and quadruple studies for Helicobacter pylori eradication in Canada
  63. Altmetric Badge
    Chapter 62 Approach to Helicobacter pylori infection in children
  64. Altmetric Badge
    Chapter 63 What role for clarithromycin in the treatment of Helicobacter pylori infection?
  65. Altmetric Badge
    Chapter 64 What is the role of bismuth in Helicobacter pylori antimicrobial resistance?
  66. Altmetric Badge
    Chapter 65 Risk factors for failure of Helicobacter pylori eradication therapy
  67. Altmetric Badge
    Chapter 66 Strategies for therapy failures: Choice of ‘back-up’ regimen determined by primary treatment for Helicobacter pylori infection
  68. Altmetric Badge
    Chapter 67 Quadruple should be first-line therapy for Helicobacter pylori infection
  69. Altmetric Badge
    Chapter 68 Quadruple therapy should be second-line treatment for Helicobacter pylori infection
  70. Altmetric Badge
    Chapter 69 Helicobacter pylori infection: expectations for future therapy
  71. Altmetric Badge
    Chapter 70 A Helicobacter pylori vaccine is essential
  72. Altmetric Badge
    Chapter 71 The agenda for the microbiologist
  73. Altmetric Badge
    Chapter 72 The agenda for the immunologist
  74. Altmetric Badge
    Chapter 73 The agenda for the histopathologist
  75. Altmetric Badge
    Chapter 74 Helicobacter infections in the new millennium: the challenge for the clinician
Attention for Chapter 51: Test-and-treat strategy in dyspepsia — the European perspective
Altmetric Badge

Mentioned by

news
3 news outlets

Citations

dimensions_citation
22 Dimensions
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Test-and-treat strategy in dyspepsia — the European perspective
Chapter number 51
Book title
Helicobacter pylori
Published by
Springer, Dordrecht, January 2000
DOI 10.1007/978-94-011-3927-4_51
Book ISBNs
978-9-40-105753-0, 978-9-40-113927-4
Authors

P. Malfertheiner